ArticleExperimental & molecular medicine2026
Pathological calcium overload impairs skeletal muscle regeneration through sustained NFAT-dependent proliferative signaling.
Article in Experimental & molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Skeletal muscle regeneration requires coordinated myoblast proliferation and differentiation. Calcium dysregulation is commonly observed in aging and disease-associated muscle weakness; however, its impact on myogenic progression remains unclear. In this study, we investigated the mechanism by which intracellular calcium overload impairs myogenic differentiation and muscle regeneration. Transcriptomic analysis of aged human muscle revealed coordinated activation of calcium signaling and proliferation pathways. In vitro calcium exposure increased myoblast proliferation under differentiation conditions while suppressing myogenic markers. RNA sequencing identified upregulation of proliferative programs with concurrent suppression of myogenic genes and enrichment of calcium-NFAT signaling. Mechanistically, calcium promoted NFATc1 nuclear translocation and upregulated Ccnd1 expression. Consistent with these in vitro findings, both ovariectomized mice (systemic calcium dysregulation) and human calcific tendinitis tissues (localized calcium overload) exhibited NFAT-associated proliferative signatures with suppressed myogenic markers. The selective NFAT inhibitor VIVIT prevented calcium-induced NFATc1 nuclear accumulation and restored myotube formation in vitro, while promoting myofiber maturation in an in vivo injury model. These findings implicate chronic calcium-NFAT signaling as a mechanism linking calcium dysregulation to impaired muscle regeneration.
Identifiers
42827110What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.